Clinical Trials Sponsored by Hubei Cancer Hospital

Total 10062 results

Hubei Cancer Hospital

Recruiting

Neoadjuvant Radiotherapy and Immediate Implant-Based Breast Reconstruction

Breast Cancer | Implant Breast Reconstruction | Neoadjuvant Radiotherapy

China
Hubei Cancer Hospital

Recruiting

Pifenidone Prophylactic Therapy for Radiation Lung Injury in Patients Who Have Previously Received Immune Checkpoint Inhibitors

Lung Cancer

China
Hubei Cancer Hospital

Enrolling by invitation

Investigating the Effects of Different Incision Types on Aesthetic Outcomes and Incision-related Complications After Breast Reconstruction Surgery

Breast Neoplasm Female

China
Hubei Cancer Hospital

Completed

Chemoradiotherapy for Patients With Locally Advanced Nasopharyngeal Carcinoma Using Raltitrexed-Cisplatin

Nasopharyngeal Carcinoma

China
Hubei Cancer Hospital

Enrolling by invitation

Apatinib Combined With Radiotherapy in Patient With BM From Drive Gene Negative NSCLC

NSCLC

China
Hubei Cancer Hospital

Recruiting

Omitting CTV for Locally Advanced NSCLC Responded to Immunotherapy and Chemotherapy

Non Small Cell Lung Cancer | Radiotherapy | Immunotherapy | Locally Advanced

China
Hubei Cancer Hospital

Recruiting

Selected De-escalation Radiotherapy for Postoperative Head and Neck Squamous Cell Carcinoma (iCSDeR)

Surgery | Head and Neck Squamous Cell Carcinoma | Radiotherapy | Immunotherapy

China
Hubei Cancer Hospital

Recruiting

Impact of Baduanjin Qigong Exercise on Fatigue in Patients With NSCLC Undergoing Adjuvant Chemotherapy

Fatigue

China
Hubei Cancer Hospital

Recruiting

Toripalimab Combined With Anlotinib and SBRT in Patients With Untreated Brain Metastases of Driven Gene-negative NSCLC

NSCLC

China
Hubei Cancer Hospital

Recruiting

Ondanstron Weekly vs Every 3 Weeks for Prevention of Nausea and Vomiting Induced by Chemotherapy Combined With PD-1 Blockade

Nausea With Vomiting Chemotherapy-Induced

China
Hubei Cancer Hospital

Recruiting

Primary Tumor Radiotherapy Omitting CTV for Patients With Advanced NSCLC Responded to Immunotherapy and Chemotherapy

Radiotherapy | Immunotherapy | Advanced Non-Small Cell Squamous Lung Cancer

China
Hubei Cancer Hospital

Recruiting

Single-drug Chemotherapy Plus Immunotherapy in Metastatic Non-small Cell Lung Cancer Elderly Patients

Metastatic Lung Cancer | Elderly Patients

China
Hubei Cancer Hospital

Recruiting

Surufatinib With or Wothout Immunotherapy for Advanced Colorectal Cancer in Later Line

Colorectal Neoplasms

China
Hubei Cancer Hospital

Recruiting

The Risk Factors for Acute Radiation Pneumonitis in Patients With Prior Receipt of Immune Checkpoint Inhibitors

Cancer Patients

China
Hongmei Zheng

Recruiting

The Benefits of Continued Use of Ovarian Function Suppression After 5 Years

Endocrine Therapy | Breast Cancer Female

China
Wuhan University
Tongji Hospital; Hubei Cancer Hospital

Withdrawn

A Study of SBRT in Combination With rhGM-CSF for Stage IV NSCLC Patients Who Failed in Second-line Chemotherapy

Carcinoma, Non-Small-Cell Lung

China
Xinhong Wu, PhD

Completed

Clinical Significance of Supraclavicular Lymph Node Dissection for Breast Cancer

Breast Cancer Stage III

China
Li Zhang
Hubei Cancer Hospital

Not yet recruiting

SBRT Combined With Osimertinib Compared With Osimertinib for Stage IV NSCLC

Stage IV Non-small Cell Lung Cancer

China
Hui ting Xu，MD

Unknown

Clinical Study of Autologous Erythrocytes Derived MPs Packaging MTX Peritoneal Perfusion to Treat Malignant Ascites

Malignant Ascites

China
Wuling Ou
Jiangsu HengRui Medicine Co., Ltd.; Hubei Clinical Research Collaboration Group

Unknown

Apatinib Mesylate Combined With Pemetrexed in the Treatment of Pretreated Advanced Non-squamous Non-small Cell Lung Cancer

Nonsmall Cell Lung Cancer

China
Hebei Tumor Hospital

Unknown

Pilot Study of Zoledronic Acid in Combination With First-line Chemotherapy in Aged Patients With Lung Cancer

Lung Cancer

China
Hebei Tumor Hospital

Unknown

A Study of Raltitrexed Plus Docetaxel Versus Docetaxel as Second-line Chemotherapy in Subjects With Gastric Cancer

Gastric Cancer

China
Hebei Tumor Hospital

Unknown

Study Comparing Sequential Therapy of S1+Docetaxel Followed by S1 to Concomitant S1+Docetaxel for Advanced Gastric Cancer

Gastric Cancer

China
Hebei General Hospital

Unknown

Cognitive Impairment , Neuroimaging and Inflammatory Markers in Patients With Subcortical Ischemic Vascular Disease

Other Generalized Ischemic Cerebrovascular Disease

China
Hebei General Hospital

Completed

Effect of Acupuncture Combined With Biofeedback Electrical Stimulation on SUI

Stress Urinary Incontinence

China
Hebei Tumor Hospital

Unknown

Safety and Efficacy of Ginsenoside Rg3 in Combination With First-line Chemotherapy in Advanced Gastric Cancer

Self Efficacy

China
Sheng Hu
Wuhan Binhui Biotechnology Co., Ltd.

Recruiting

Safety and Efficacy Study of Virus Activated Killer Immune Cells (VAK) for Malignant Pleural and Peritoneal Effusion

Malignant Pleural Effusion | Malignant Peritoneal Effusion

China
Hubei Hospital of Traditional Chinese Medicine

Unknown

Electroacupuncture Combined With Umbilical Moxibustion on Abdominal Obesity of Yang Deficiency

Obesity, Abdominal
Hubei Hospital of Traditional Chinese Medicine

Unknown

Herb-partitioned Moxibustion Plus Lifestyle Modification Treatment for Simple Obesity

Obesity

China
Hubei Hospital of Traditional Chinese Medicine

Not yet recruiting

Evaluation of the Clinical Efficacy of Moxibustion With Regulating Yin and Yang in the Treatment of Menopausal Obesity

Obesity

China
Hubei Hospital of Traditional Chinese Medicine

Completed

Efficacy of Electro-acupuncture for Abdominal Obesity: Study for a Randomized Controlled Trial

Obesity, Abdominal

China
Hubei Hospital of Traditional Chinese Medicine

Completed

Effect of Gargle Containing Honeysuckle and Semen Oroxyli

Pain | Obstructive Sleep Apnea | Complication

China
Hebei Province Veterans Hospital

Completed

Dance/Movement Therapy for Bone Mineral Density in Schizophrenia

Schizophrenia

China
Hebei Yanda Ludaopei Hospital

Completed

LILRB4 STAR-T Cells in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia

Relapsed/Refractory Acute Myeloid Leukemia

China
Hebei Yanda Ludaopei Hospital

Not yet recruiting

Study on Intelligent Nutrition Support Therapy for Hematopoietic Stem Cell Transplantation Recipients

Nutrition Aspect of Cancer | Stem Cell Transplant Complications
Hebei Yanda Ludaopei Hospital

Unknown

A Study of BCMA-directed CAR-T Cells Treatment in Subjects With r/r Multiple Myeloma

Relapsed or Refractory Multiple Myeloma

China
Hebei Senlang Biotechnology Inc., Ltd.
Hebei Yanda Ludaopei Hospital

Recruiting

Safety and Efficacy of CD19/CD22 Dual Targeted CAR-T Cell Therapy in R/R B-Cell Acute Lymphoblastic Leukemia

CD19+ and CD 22+ B-ALL

China
Hebei Senlang Biotechnology Inc., Ltd.
Hebei Yanda Ludaopei Hospital

Active, not recruiting

Senl_1904A and Senl_1904B Chimeric Antigen Receptor （CAR） T-Cell in the Treatment of r/ r Acute B Lymphocytic Leukemia

Acute Lymphocytic Leukemia

China
Zhou Fuxiang
Hubei Cancer Hospital; Henan Provincial People's Hospital; Huangshi Central Hospital...

Recruiting

Apatinib Plus Camrelizumab Combined With Docetaxel and S1 in First-line Treatment for Metastatic Gastric Cancer

Metastatic Gastric Adenocarcinoma | Metastatic Gastroesophageal Junction Adenocarcinoma

China
Tongji Hospital
Xiangya Hospital of Central South University; Chinese PLA General Hospital; Hubei...

Recruiting

Cystoprostatectomy Versus Radiotherapy Combined With ADT for the Treatment of cT4 Prostate Cancer With Bladder Invasion (CRADT)

Prostate Cancer

China
Hebei Senlang Biotechnology Inc., Ltd.
Hebei Yanda Ludaopei Hospital

Unknown

Study Evaluating Safety and Efficacy of CAR-T Cells Targeting CD123 in Patients With Acute Myelocytic Leukemia

Acute Myelocytic Leukemia

China
Hui ting Xu，MD
Jiangsu HengRui Medicine Co., Ltd.

Unknown

Clinical Study of Apatinib and 5-Fu Combination Regimen to Treat Advanced Colorectal Cancer Patients

Metastatic Colorectal Cancer

China
Shanghai 10th People's Hospital
Chibi People's Hospital, Hubei Province

Unknown

Clinical Characteristics and Prognostic Factors of Patients With COVID-19

Coronavirus

China
Hebei Yanda Hospital
Beijing Tiantan Hospital

Unknown

Safety and Efficacy of IDH1R132H-DC Vaccine in Gliomas

Glioma

China
Hebei Yanda Hospital
Beijing Tiantan Hospital

Unknown

Ultra-low Dose Bevacizumab Plus Temozolomide for Recurrent High-grade Gliomas

Recurrent High-grade Glioma

China
Suzhou Genhouse Bio Co., Ltd.
Zhejiang Cancer Hospital; Henan Cancer Hospital; Hubei Cancer Hospital; The First...

Recruiting

A Phase Ia/Ib Study of GH2616 Tablet in Subjects With Advanced Solid Tumors

Advanced Solid Tumors

China
Hebei Senlang Biotechnology Inc., Ltd.
Hebei Medical University Fourth Hospital

Recruiting

Clinical Trial of CAR-T in the Treatment of Relapsed and Refractory Hematopoietic and Lymphoid Tissue Tumors in Children

Lymphoma | Leukemia

China
Hebei Senlang Biotechnology Inc., Ltd.
Hebei Medical University Fourth Hospital

Recruiting

Multicenter Clinical Study on the Safety and Effectiveness of CAR-T in the Treatment of Relapsed/Refractory Plasma Cell Tumors

Plasma Cell Tumors

China
Zhou Fuxiang
Xiangya Hospital of Central South University; Henan Cancer Hospital; Hubei Cancer... and other collaborators

Recruiting

Fruquintinib Combined With mFOLFOX6/FOLFIRI in First-line Treatment for Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

China
Hebei Medical University Fourth Hospital

Recruiting

Durvalumab Combined With Chemoradiotherapy for Limited Stage Small Cell Lung Cancer (Camel-01)

SCLC, Limited Stage

China

3

Subscribe